Biohaven BHVN
NYSE BHVN
$15.69 -0.17 (-1.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Biohaven (BHVN) Price to Book (2022 - 2026)

Analysis

Biohaven (BHVN) Price to Book (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Biohaven 2.37 Bn 2.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 183.86
Mar 31, 2026 9.83
Dec 31, 2025 23.33
Sep 30, 2025 -92.55
Jun 30, 2025 11.09
Mar 31, 2025 9.46
Dec 31, 2024 8.93
Sep 30, 2024 15.01
Jun 30, 2024 8.35
Mar 31, 2024 14.84
Dec 31, 2023 8.11
Sep 30, 2023 6.13
Jun 30, 2023 4.22
Mar 31, 2023 1.97
Dec 31, 2022 1.15
Sep 30, 2022 2.47